###### Impact Summary

Despite much progress in our understanding of the genetic basis of aging, mainly from studying large‐effect mutants, little is known about natural variants that contribute to the evolution of lifespan and related fitness traits. To identify the mechanisms by which longevity evolves, we sequenced a set of *D. melanogaster* populations that have been undergoing selection for late‐life reproduction and postponed senescence, relative to unselected controls, for over 35 years. Instead of an enrichment of evolutionary changes in previously identified "canonical" longevity genes, we found an enrichment of genetically diverged immunity genes, suggesting that variation in immune function contributes to the evolution of lifespan and late‐life fertility. To test this hypothesis, we employed immunity assays: long‐lived flies survived infections better and showed altered age‐dependent immune gene expression as compared to control flies. Using in vivo RNAi we confirmed that reduced expression of immune genes extends lifespan while immune overactivation is strongly detrimental.

Despite major progress in our understanding of the genetic basis of aging and life history, especially in model organisms such as yeast, *C. elegans, Drosophila*, and mice (Guarente and Kenyon [2000](#evl389-bib-0028){ref-type="ref"}; Partridge and Gems [2002](#evl389-bib-0058){ref-type="ref"}; Tatar et al. [2003](#evl389-bib-0077){ref-type="ref"}; Guarente et al. [2008](#evl389-bib-0029){ref-type="ref"}; Kenyon [2010](#evl389-bib-0032){ref-type="ref"}; Flatt and Heyland [2011](#evl389-bib-0022){ref-type="ref"}), the identity and effects of naturally segregating polymorphisms that affect variation in lifespan and correlated fitness traits and which might thus underpin the evolution of longevity and life history remain poorly understood to date (De Luca et al. [2003](#evl389-bib-0014){ref-type="ref"}; Pasyukova et al. [2004](#evl389-bib-0061){ref-type="ref"}; Carbone et al. [2006](#evl389-bib-0009){ref-type="ref"}; Flatt and Schmidt [2009](#evl389-bib-0024){ref-type="ref"}; Paaby et al. [2014](#evl389-bib-0057){ref-type="ref"}; Carnes et al. [2015](#evl389-bib-0010){ref-type="ref"}; Flatt and Partridge [2018](#evl389-bib-0023){ref-type="ref"}).

Several major evolutionarily conserved pathways that regulate lifespan and correlated fitness traits, including insulin/insulin‐like growth factor 1 signaling (IIS), have been identified using analyses of large‐effect mutants and transgenes in the laboratory (Partridge and Gems [2002](#evl389-bib-0058){ref-type="ref"}; Tatar et al. [2003](#evl389-bib-0077){ref-type="ref"}; Kenyon [2010](#evl389-bib-0032){ref-type="ref"}), but to what extent genes in these "canonical" pathways harbor segregating alleles that affect lifespan is mostly unknown (Flatt and Schmidt [2009](#evl389-bib-0024){ref-type="ref"}; Paaby et al. [2014](#evl389-bib-0057){ref-type="ref"}; Carnes et al. [2015](#evl389-bib-0010){ref-type="ref"}; Flatt and Partridge [2018](#evl389-bib-0023){ref-type="ref"}). For instance, only few studies to date have identified functional effects of segregating IIS polymorphisms upon lifespan and correlated life‐history traits in populations of *Drosophila* (Paaby et al. [2010](#evl389-bib-0056){ref-type="ref"}, [2014](#evl389-bib-0057){ref-type="ref"}; Remolina et al. [2012](#evl389-bib-0066){ref-type="ref"}) or which contribute to longevity in human centenarians (Suh et al. [2008](#evl389-bib-0076){ref-type="ref"}; Willcox et al. [2008](#evl389-bib-0081){ref-type="ref"}; Flachsbart et al. [2017](#evl389-bib-0021){ref-type="ref"}; Joshi et al. [2017](#evl389-bib-0031){ref-type="ref"}).

Here, we take advantage of a \>35‐year‐long laboratory selection experiment for late‐life fertility and increased lifespan in *Drosophila melanogaster*, first published by Luckinbill and colleagues in 1984 (Luckinbill et al. [1984](#evl389-bib-0048){ref-type="ref"}; also see Luckinbill and Clare [1985](#evl389-bib-0047){ref-type="ref"}; Arking [1987](#evl389-bib-0003){ref-type="ref"}), to analyze the genomic footprints underlying the evolution of delayed reproduction and postponed aging. In this long‐term selection experiment, replicate lines derived from an outbred base population have been selected for late‐life fertility and--indirectly--for increased lifespan by breeding only from flies that survived and were fertile at a relatively old age. In contrast, unselected replicate control lines have been propagated across generations by breeding from flies with a random age at reproduction (for details see Supplementary methods). Selected flies in this experiment have evolved late‐life fertility and live ≈40--50% longer than unselected control flies, yet exhibit reduced early fecundity relative to the controls (see Supplementary methods). Thus, these selection lines are subject to a genetic trade‐off between late‐life performance (long life, late‐life fertility) and early fecundity, as is commonly observed in laboratory evolution experiments that directly or indirectly select for changes in *Drosophila* lifespan (Luckinbill et al. [1984](#evl389-bib-0048){ref-type="ref"}; Rose [1984](#evl389-bib-0068){ref-type="ref"}; Zwaan et al. [1995](#evl389-bib-0086){ref-type="ref"}; Partridge et al. [1999](#evl389-bib-0060){ref-type="ref"}; Stearns et al. [2000](#evl389-bib-0074){ref-type="ref"}; Remolina et al. [2012](#evl389-bib-0066){ref-type="ref"}).

The central finding from our genomic analysis of this selection experiment is that evolutionary changes in innate immunity contribute to the evolution of late‐life performance in fruit flies, probably by improving age‐dependent immune homeostasis. Although still little is understood about the mechanistic interplay between immunity and aging (Garschall and Flatt [2018](#evl389-bib-0025){ref-type="ref"}), our analyses suggest that immune function is a major longevity assurance mechanism that can be targeted by selection on standing genetic variation.

Results and Discussion {#evl389-sec-0020}
======================

POOL‐SEQ IDENTIFIES A GENOME‐WIDE SIGNATURE OF LONGEVITY {#evl389-sec-0030}
--------------------------------------------------------

To characterize the genomic signature of longevity we used next‐generation pool‐sequencing (Pool‐seq) (Schlötterer et al. [2014](#evl389-bib-0072){ref-type="ref"}) to obtain genome‐wide allele frequency estimates from four long‐lived selection lines and two unselected control lines after ≥ 144 generations of selection (see Supplementary methods for details). We identified candidate SNPs by comparing allele frequency differentiation between the selection and control regimes with a stringent *F* ~ST~ outlier approach (Lewontin and Krakauer [1973](#evl389-bib-0042){ref-type="ref"}; Akey [2009](#evl389-bib-0002){ref-type="ref"}) (Fig. [1](#evl389-fig-0001){ref-type="fig"}A,B). The majority of SNPs (62.2%) showed no or less differentiation between the selection versus control regime as compared to differentiation within these regimes (selection signal‐to‐noise ratio ≤ 0; Fig. [1](#evl389-fig-0001){ref-type="fig"}B,C). We defined SNPs as candidates if they showed very strong, consistent and significant differentiation in all eight pairwise comparisons between the four selection and two control lines (signal‐to‐noise ratio ≈ 0.9; *F* ~ST(selection\ vs.\ control)~ \> 0.9; Bonferroni‐corrected Fisher\'s exact test: *P* \< 10^−9^) (Fig. [1](#evl389-fig-0001){ref-type="fig"}A,B,C). Using this approach, we identified 8205 candidate SNPs in 868 genes distributed across the entire genome (Fig. [1](#evl389-fig-0001){ref-type="fig"}B; Table [S1](#evl389-supl-0002){ref-type="supplementary-material"}; genes were defined as the sequence between the ends of the 5' and 3' UTRs plus 1 kb up‐ and downstream; also see Supplementary methods). Candidate loci appeared to cluster non‐randomly in specific genomic regions, suggesting pervasive polygenic selection and/or indirect selection due to "hitchhiking" ("genetic draft") (Fig. [1](#evl389-fig-0001){ref-type="fig"}B; Table [S1](#evl389-supl-0002){ref-type="supplementary-material"}). To further validate our set of longevity candidate SNPs and to exclude false positives due to randomness, for example because of genetic drift, we used a combinatorial approach (see Supplementary methods). We found that--when applying our stringent candidate criteria -- it is highly unlikely (*P* ≈ 1.6 × 10^−4^) that this large number of candidate SNPs arose by chance (Fig. [1](#evl389-fig-0001){ref-type="fig"}D).

![**Genomic response to longevity selection. (A)** Identification of longevity candidates. To identify candidate SNPs that have likely been shaped by selection for longevity we performed all eight pairwise *F* ~ST~ comparisons between the two unselected control lines (C1, C2) and the four long‐lived selection lines (S1, S2, S3, S4). SNPs were defined to represent candidates if *F* ~ST(selection\ vs.\ control)~ \> 0.9 in all eight pairwise comparisons and if they showed significant allele frequency differentiation between the selection and control regime (Fisher\'s Exact test, Bonferroni *P* \< 10^−9^). See Supplementary methods for details. Using this stringent *F* ~ST~ outlier approach we identified 8205 candidate SNPs belonging to 868 genes. **(B)** Genomic "selection signal" relative to "noise." To quantify the strength of genetic differentiation among the selection and control lines ("selection signal") relative to differentiation within control or selection lines ("noise") we calculated a "selection signal"‐to‐noise ratio. This ratio provides a measure of average *F* ~ST~ differentiation among the selection versus control regime relative to *F* ~ST~ differentiation within regimes (see Supplementary methods). Positive values of this log~2~ *F* ~ST~ ratio indicate larger differentiation among regimes relative to within regimes, thus representing a "signal" of selection. The genome‐wide distribution of this ratio has a mode ≈ 0, indicating equal differentiation among and within regimes. Only a very small fraction of SNPs has a ratio ≈ 1 that would indicate complete allelic fixation (*F* ~ST~ = 1) among regimes, without any differentiation within regimes. We focused our genomic analysis on candidate SNPs that represent extreme *F* ~ST~ outliers with a ratio of ≈ 0.9. **(C)** Genomic locations of candidate SNPs. log~2~ *F* ~ST~ ratio as function of genomic position on chromosomal arms *X*, *2L*, *2R*, *3L*, and *3R*. Candidate SNPs are shown in red and noncandidates (i.e., nonsignificant genomic background) in gray. Note the vast excess of highly differentiated SNPs in the selection versus control regime comparisons (values \> 0), in marked contrast to the much weaker differentiation within the control and selection regimes (values \< 0). **(D)** Number of candidate SNPs in different combinations of eight pairwise comparisons. To define candidate SNPs we performed all possible eight pairwise comparisons between two control and four selection lines and used a stringent *F* ~ST~ outlier approach (see Supplementary methods). This yielded 8205 candidate SNPs (red bar) belonging to 868 candidate genes. To verify that this number of candidate SNPs is not due to chance we applied our candidate criteria to all 6435 possible sets of eight pairwise comparisons; out of these combinations only one set is biologically informative in terms of inferring selection, that is the set of all eight pairwise control versus selection comparisons (see Supplementary methods). No combination of eight pairwise comparisons yielded as many candidate SNPs as this "true" set of comparisons (red bar), with a probability that the "true" number of candidate SNPs is due to chance of *P* ≈ 1.6 × 10^−4^.](EVL3-2-567-g001){#evl389-fig-0001}

LONGEVITY CANDIDATE GENES EXHIBIT GENETIC PARALLELISM {#evl389-sec-0040}
-----------------------------------------------------

While some mechanisms of longevity are evolutionarily conserved ("shared") among species and thus "public," for example insulin/insulin‐like growth factor 1 signaling (IIS), most others are likely to be lineage‐specific and thus 'private' (Martin et al. [1996](#evl389-bib-0049){ref-type="ref"}; Partridge and Gems [2002](#evl389-bib-0058){ref-type="ref"}; McElwee et al. [2007](#evl389-bib-0051){ref-type="ref"}). Similarly, at the intraspecific level, parallel and convergent evolution in independent populations might result in the repeated use of the same genes underlying a given trait ("gene reuse") (Conte et al. [2012](#evl389-bib-0012){ref-type="ref"}), but to what extent this might be the case for longevity remains unclear. Addressing this question might give insights into the predictability of the evolution of lifespan at the genetic level (Stern and Orgogozo [2008](#evl389-bib-0075){ref-type="ref"}; Conte et al. [2012](#evl389-bib-0012){ref-type="ref"}).

To examine how frequently the same genes are used by different populations during the evolution of late‐life fertility and longevity, we compared our list of candidate genes to those from two other "Evolve and Resequence" studies of *Drosophila* longevity and correlated life‐history traits (Remolina et al. [2012](#evl389-bib-0066){ref-type="ref"}; Carnes et al. [2015](#evl389-bib-0010){ref-type="ref"}). The study by Carnes et al. ([2015](#evl389-bib-0010){ref-type="ref"}) provides a genomic analysis of an independent long‐term selection experiment by Rose (Rose [1984](#evl389-bib-0068){ref-type="ref"}) similar in duration to ours (Luckinbill et al. [1984](#evl389-bib-0048){ref-type="ref"}), with both selection experiments first published back‐to‐back in 1984. The other study, by Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"}), performed whole‐genome sequencing of a shorter, 50‐generation‐long selection experiment for longevity. Importantly, both Rose ([1984](#evl389-bib-0068){ref-type="ref"}) and Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"}) selected for increased lifespan by postponing reproduction, using a design that is qualitatively identical to ours.

We discovered statistically significant sharing of candidate loci across all possible overlaps among the three datasets (Fig. [2](#evl389-fig-0002){ref-type="fig"}, Table [S2](#evl389-supl-0003){ref-type="supplementary-material"}), indicating genetic parallelism underlying the evolution of late‐life performance. Our dataset contained 147 (11.7%) of the candidate genes of Carnes et al. ([2015](#evl389-bib-0010){ref-type="ref"}) and 102 (10.9%) of those of Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"}). Twenty candidate genes (∼2%) were shared across all three studies, representing clear cases of gene reuse during the evolution of longevity and late‐life fertility (Fig. [2](#evl389-fig-0002){ref-type="fig"}, Table [S2](#evl389-supl-0003){ref-type="supplementary-material"}). Thus, as might be expected from a highly complex and polygenic trait such as lifespan (McElwee et al. [2007](#evl389-bib-0051){ref-type="ref"}), most candidate loci tend to be population‐specific. However, a small but significant proportion of candidate loci is shared among independent populations, perhaps suggesting the existence of "preferred" loci of evolutionary change (Stern and Orgogozo [2008](#evl389-bib-0075){ref-type="ref"}) for longevity. Several of these "high confidence" genes represent promising candidate loci for future functional experiments.

![**Sharing of candidate genes across three independent genomic analyses of longevity selection in *Drosophila***. The Venn diagram shows statistically significant overlaps between the candidate genes identified in our study and those of Carnes et al. ([2015](#evl389-bib-0010){ref-type="ref"}) and Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"}), calculated with the R package *SuperExactTest* (see Supplementary methods). The results indicate that -- across different populations of *D. melanogaster*--there exists genetic parallelism ("gene reusage") underlying the evolution of longevity. See Table [S2](#evl389-supl-0003){ref-type="supplementary-material"} for functional annotations of the shared longevity candidate genes; see Table [S5](#evl389-supl-0006){ref-type="supplementary-material"} for statistical details.](EVL3-2-567-g002){#evl389-fig-0002}

Notably, although each study identified several loci that belong to "canonical" longevity pathways (Guarente and Kenyon [2000](#evl389-bib-0028){ref-type="ref"}; Partridge and Gems [2002](#evl389-bib-0058){ref-type="ref"}; Tatar et al. [2003](#evl389-bib-0077){ref-type="ref"}; Guarente et al. [2008](#evl389-bib-0029){ref-type="ref"}; Kenyon [2010](#evl389-bib-0032){ref-type="ref"}), for example the IIS pathway, the candidate lists and overlaps contain few "classical" lifespan genes that have previously been identified in studies of large‐effect mutants and transgenes. This might be due to a lack of standing variation at these "canonical" longevity loci: perhaps these conserved‐effect loci have been optimized by selection but are now subject to strong purifying selection (see Remolina et al. [2012](#evl389-bib-0066){ref-type="ref"}; Flatt and Partridge [2018](#evl389-bib-0023){ref-type="ref"}). Thus, while segregating IIS polymorphisms with major effects on life‐history traits including lifespan have been identified (Geiger‐Thornsberry and Mackay [2004](#evl389-bib-0027){ref-type="ref"}; Paaby et al. [2010](#evl389-bib-0056){ref-type="ref"}, [2014](#evl389-bib-0057){ref-type="ref"}; Flachsbart et al. [2017](#evl389-bib-0021){ref-type="ref"}; Joshi et al. [2017](#evl389-bib-0031){ref-type="ref"}), our results are consistent with the hypothesis that loci in these canonical pathways might be under selective constraints (see Remolina et al. [2012](#evl389-bib-0066){ref-type="ref"}; Flatt and Partridge [2018](#evl389-bib-0023){ref-type="ref"}).

Even though "canonical" longevity loci seem to be underrepresented, many of the overlapping candidate genes that we have identified have strong empirical support from functional genetics, GWAS, QTL, or gene expression studies, with known roles in lifespan determination, somatic maintenance (e.g., resistance against starvation or oxidative stress, immunity, metabolism), and age‐specific fecundity (see functional annotations in Table [S2](#evl389-supl-0003){ref-type="supplementary-material"}). The fact that several candidate loci are known to affect age‐specific fecundity is consistent with the age‐at‐reproduction selection regime used by all three studies and possibly also with genetic trade‐offs between early fecundity and lifespan (and/or late‐life fecundity) seen in these selection experiments.

LONGEVITY CANDIDATE GENES ARE ENRICHED FOR IMMUNE FUNCTION {#evl389-sec-0050}
----------------------------------------------------------

We next sought to characterize the functions of our candidate loci with gene ontology (GO) analysis (Kofler and Schlötterer [2012](#evl389-bib-0035){ref-type="ref"}) (Table [S3](#evl389-supl-0004){ref-type="supplementary-material"}; considering the ontologies "Biological Function," "Molecular Function," and "Cellular Component"). Interestingly, we found an enrichment of candidate genes associated with "antifungal peptides" with a false discovery rate of ∼9% (FDR = 0.085), whereas the term "determination of adult lifespan" had no support (FDR = 1) (Table [S3](#evl389-supl-0004){ref-type="supplementary-material"}). Immunity against fungi (and gram‐positive bacteria) is regulated by Toll signaling (Belvin and Anderson [1996](#evl389-bib-0007){ref-type="ref"}; Lemaitre et al. [1996](#evl389-bib-0040){ref-type="ref"}; De Gregorio et al. [2002](#evl389-bib-0013){ref-type="ref"}; Valanne et al. [2011](#evl389-bib-0080){ref-type="ref"}), and among our candidates we identified several prominent members of this pathway, including the Toll ligand *spätzle* (*spz*), the receptor *Toll* (*Tl*), the Toll inhibitor *cactus* (*cact*), the NFκB transcription factors *Dorsal‐related immunity factor* (*Dif*) and *dorsal* (*dl*), the upstream serine proteases *persephone* (*psh*) and *sphinx2*, and two regulators of *cactus*, *scalloped* (*sd*) and *cactin* (Fig. [3](#evl389-fig-0003){ref-type="fig"}, Table [S4](#evl389-supl-0005){ref-type="supplementary-material"}). The other major immune pathway, the Imd pathway (De Gregorio et al. [2002](#evl389-bib-0013){ref-type="ref"}; Kleino and Silverman [2014](#evl389-bib-0034){ref-type="ref"}; Myllymäki et al. [2014](#evl389-bib-0054){ref-type="ref"}), also harbored several but fewer candidates, including *peptidoglycan recognition protein LE* (*PRGP‐LE*) and the antimicrobial peptide *Cecropin A1* (*CecA1*) (Fig. [3](#evl389-fig-0003){ref-type="fig"}, Table [S4](#evl389-supl-0005){ref-type="supplementary-material"}).

![**Genes of the Toll and Imd pathways represent longevity candidates**. Overview of the Toll and Imd pathways, the two major pathways regulating the humoral innate immune response against fungi and gram‐positive bacteria (Toll) and gram‐negative bacteria (Imd). Among our longevity candidates we found an enrichment of immunity‐related genes (enrichment of GO terms associated with "antifungal peptides"). Longevity candidate genes identified in the Toll and Imd pathways are shown in red. For additional immunity‐related candidate genes see Table [S4](#evl389-supl-0005){ref-type="supplementary-material"}.](EVL3-2-567-g003){#evl389-fig-0003}

The enrichment of immunity genes prompted us to hypothesize that genetic changes in immune function might contribute to the evolution of longevity and correlated fitness traits (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Finch [2007](#evl389-bib-0020){ref-type="ref"}). Importantly, Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"}) also found enrichment of genes involved in "defense response to fungus," and Carnes et al. ([2015](#evl389-bib-0010){ref-type="ref"}) observed divergence in immune gene expression between long‐lived selection and control lines, suggesting that the relation between immunity and lifespan might be general (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Finch [2007](#evl389-bib-0020){ref-type="ref"}). While we found a larger number of genes in the Toll pathway, Carnes et al. ([2015](#evl389-bib-0010){ref-type="ref"}) and Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"}) found more candidates in the Imd pathway. However, several immune genes are shared across the three studies, despite a relatively small overlap at the individual gene level (Table [S4](#evl389-supl-0005){ref-type="supplementary-material"}). Immunity might thus represent a general mechanism underlying longevity, with immune genes having pleiotropic effects on lifespan and correlated fitness components.

Despite this compelling commonality across independent experiments, still little is known about how immunity proximately affects longevity and correlated fitness traits; similarly, whether genetic changes in immunity might contribute to the evolution of longer life remains unknown (Garsin et al. [2003](#evl389-bib-0026){ref-type="ref"}; DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Kurz and Tan [2004](#evl389-bib-0037){ref-type="ref"}; Libert et al. [2006](#evl389-bib-0043){ref-type="ref"}; Troemel et al. [2006](#evl389-bib-0079){ref-type="ref"}; Libert et al. [2008](#evl389-bib-0044){ref-type="ref"}; Fernando et al. [2014](#evl389-bib-0018){ref-type="ref"}; Guo et al. [2014](#evl389-bib-0030){ref-type="ref"}; McCormack et al. [2016](#evl389-bib-0050){ref-type="ref"}; Kounatidis et al. [2017](#evl389-bib-0036){ref-type="ref"}; Loch et al. [2017](#evl389-bib-0046){ref-type="ref"}; Yunger et al. [2017](#evl389-bib-0082){ref-type="ref"}). We therefore aimed to test whether the evolved genomic signature of immune gene enrichment observed in our study -- and similarly by Carnes et al. ([2015](#evl389-bib-0010){ref-type="ref"}) and Remolina et al. ([2012](#evl389-bib-0066){ref-type="ref"})--might represent a physiological mechanism underlying evolutionary changes in lifespan and late‐life fertility.

LONG‐LIVED FLIES SHOW REDUCED IMMUNE INDUCTION WITH AGE {#evl389-sec-0060}
-------------------------------------------------------

We first examined whether the selection and control lines differ in the expression of antimicrobial peptides (AMPs), the major effectors of the innate immune response. We used three AMPs as readouts of Toll and Imd signaling activity, *Drosomycin* (*Drs*), *Attacin A* (*AttA*), and *Diptericin* (*Dpt*). *Drs* and *AttA* are regulated by both Toll and Imd signaling, whereas *Dpt* is mainly regulated by the Imd pathway (De Gregorio et al. [2002](#evl389-bib-0013){ref-type="ref"}). Using quantitative real‐time PCR, we determined mRNA levels of young (5--6‐day‐old) and aged (25--26‐day‐old) female flies, either without pricking, upon aseptic pricking (mock control) or upon prick infection with *Erwinia carotovora carotovora 15* (*Ecc 15*). Systemic infections with this bacterium induce the expression of all three AMPs assayed here (Lemaitre et al. [1997](#evl389-bib-0041){ref-type="ref"}; Basset et al. [2000](#evl389-bib-0006){ref-type="ref"}; De Gregorio et al. [2002](#evl389-bib-0013){ref-type="ref"}).

Without pricking, control flies upregulated AMP baseline expression with age (Fig. [4](#evl389-fig-0004){ref-type="fig"}A) -- a pattern that is commonly observed in wild‐type flies and attributed to persistent chronic infection and a prolonged immune response at old age (Seroude et al. [2002](#evl389-bib-0073){ref-type="ref"}; DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Zerofsky et al. [2005](#evl389-bib-0083){ref-type="ref"}; Ren et al. [2007](#evl389-bib-0067){ref-type="ref"}; Ramsden et al. [2008](#evl389-bib-0064){ref-type="ref"}). In marked contrast to control flies, baseline AMP levels remained constant as a function of age in selected flies (Fig. [4](#evl389-fig-0004){ref-type="fig"}A).

![**Age‐dependent differential expression of immunity genes. (A)** Baseline mRNA expression levels of three antimicrobial peptides (AMPs), *Drosomycin* (*Drs*), *Attacin A* (*AttA*), and *Diptericin* (*Dpt*) in uninfected (nonpricked) young (5--6‐day‐old) and aged (25--26‐day‐old) female flies. The panel shows relative expression levels (based on efficiency‐corrected ∆Ct‐values), normalized to the geometric mean of two control transcripts, *Rp49* (*RpL32*) and *Gapdh2*. Unselected control flies upregulate AMP expression with age, but selected flies do not (ANOVA; significant Age x Regime interactions for *Drs*: *P* = 0.003 and for *AttA*: *P* = 0.005; while for *Dpt* the interaction was not significant, a post‐hoc test revealed that at old age *Dpt* levels were significantly lower in selected than in control flies: *P* = 0.038). Error bars shows standard errors of the mean. See Table [S5](#evl389-supl-0006){ref-type="supplementary-material"} for full details of statistical analysis. **(B)** Induction of *Drs*, *AttA*, and *Dpt* upon prick infection of young (5--6‐day‐old) and aged (25--26‐day‐old) female flies with *Erwinia carotovora carotovora 15* (*Ecc15*) relative to aseptic prick (mock) controls, 4--6 hours after jabbing. The panel shows the ratio of the expression values for infected relative to uninfected (mock prick control) flies, based on efficiency‐corrected ∆Ct‐values normalized to the geometric mean of two control transcripts, *Rp49* (*RpL32*) and *Gapdh2*. Relative to mock infected flies, AMP induction upon infection in long‐lived flies tends to be slightly higher at young age, but lower at old age (ANOVA on expression ratios (infected/mock infected); significant Age x Regime interactions for *Drs*: *P* = 0.026 and for *AttA*: *P* = 0.03; the same trend, albeit not significant, is seen for *Dpt*). Error bars shows standard errors of the mean. Full statistical details are given in Table [S5](#evl389-supl-0006){ref-type="supplementary-material"}.](EVL3-2-567-g004){#evl389-fig-0004}

AMP expression also differed substantially between control and selected flies upon infection: at young age, the AMP response was slightly stronger in long‐lived flies than in control flies, whereas at old age long‐lived flies tended to downregulate AMP induction (Fig. [4](#evl389-fig-0004){ref-type="fig"}b). Thus, unlike aged wild‐type flies which upregulate AMPs but suffer from immunosenescence and show signs consistent with chronic inflammation (i.e., reduced infection survival, increased bacterial load, more persistent AMP induction upon infection; see Zerofsky et al. [2005](#evl389-bib-0083){ref-type="ref"}; Ren et al. [2007](#evl389-bib-0067){ref-type="ref"}; Ramsden et al. [2008](#evl389-bib-0064){ref-type="ref"}; Myllymäki et al. [2014](#evl389-bib-0054){ref-type="ref"}), aged long‐lived selected flies exhibit restrained AMP expression.

Our results therefore suggest that long‐lived flies might have evolved improved age‐dependent immune homeostasis and alleviated immunosenescence (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}). These evolutionary changes in immune gene induction might also be linked to the late‐life fertility of the long‐lived lines. Since in our selection experiment lifespan was selected for by postponing reproduction, the observed differences in immune gene induction between the regimes might be a byproduct of selection for increased late‐life fertility in the long‐lived selection lines. This would be consistent with the observation that infection reduces fecundity: infection‐induced synthesis of AMPs incurs a cost of reproduction in wild‐type flies but this cost is abolished in Imd pathway mutants (Zerofsky et al. [2005](#evl389-bib-0083){ref-type="ref"}).

LONG‐LIVED FLIES HAVE IMPROVED SURVIVAL UPON INFECTION {#evl389-sec-0070}
------------------------------------------------------

To investigate whether selected and control flies differ in realized immune function we measured their survival after infection with four different pathogens (Fig. [5](#evl389-fig-0005){ref-type="fig"}). Long‐lived flies survived infections with a fungus (*Beauveria bassiana*, *Bb*), with the Gram‐negative bacterium *Ecc15* and with the Gram‐positive bacterium *Enterococcus faecalis* (*Ef*) overall markedly better than control flies (Fig. [5](#evl389-fig-0005){ref-type="fig"}A,B,C,E). Improved survival of long‐lived flies was observed for both young and aged flies after infection with *Bb* and *Ecc15*, whereas for *Ef* infection only aged long‐lived flies showed increased survival relative to controls (Fig. [5](#evl389-fig-0005){ref-type="fig"}A,B,C,E). Because one of our candidate genes, the JAK/STAT activating cytokine *unpaired3* (*upd3*; Table [S4](#evl389-supl-0005){ref-type="supplementary-material"}), is involved in antiviral immunity (Zhu et al. [2013](#evl389-bib-0084){ref-type="ref"}), we also measured the survival of flies upon infection with *Drosophila* C virus (DCV). This assay was carried out only with young, not aged flies, but we again found that long‐lived flies survived infection with DCV much better than control flies (Fig. [5](#evl389-fig-0005){ref-type="fig"}D,E). The evolution of prolonged lifespan might thus be accompanied--or partly be caused -- by selection for improved realized immunity.

![**Long‐lived flies survive infections better than control flies. (A--D)** Survival of selected and control flies upon infection with the fungus *Beauveria bassiana* (*Bb*) **(A)**, the gram‐negative bacterium *Erwinia carotovora carotovora 15* (*Ecc15*) **(B)**, the gram‐positive bacterium *Enterococcus faecalis* (*Ef*) **(*C*)**, and with *Drosophila* C virus (*DCV*) **(D)**. Except for DCV infection, assays were performed with both young (1--4‐days‐old) and aged (22--25‐days‐old) female flies. All survival assays were terminated after 7 days and the remaining flies censored for analysis. Red curves show average survival of selection lines and black curves survival of control lines; dashed lines represent young flies and solid lines aged flies. For statistics see Fig. [4](#evl389-fig-0004){ref-type="fig"}E and Table [S5](#evl389-supl-0006){ref-type="supplementary-material"}. **(E)** Summary of infection‐induced mortality in selection and control lines. Shown are estimates of the hazard ratios of selection relative to control lines; negative values indicate superior survival of selection lines relative to control lines. *P*‐values for the effect of regime are from Cox (proportional hazards) regression with *χ* ^2^ tests; ^\*^ *P* \< 0.05, ^\*\*\*^ *P* \< 0.001. Error bars show the lower and upper 95^th^ percentiles; see Table [S5](#evl389-supl-0006){ref-type="supplementary-material"} for statistical details. **(F)** Clearance ability of selection and control lines over a 6‐day postinfection period. Percentage of successful (100%) clearance of young (5--6‐days old) and aged (23--25‐days old) female flies after infection with *Ecc15*. Error bars show binomial standard errors. Binomial GLM revealed a significant Age x Regime interaction (*P* = 0.018): clearance stays constant with age in selected flies but starts out higher and then declines with age in control flies; this might be consistent with the hypothesis that selected flies are more tolerant. Details of statistical analysis are given in Table [S5](#evl389-supl-0006){ref-type="supplementary-material"}.](EVL3-2-567-g005){#evl389-fig-0005}

Next, we examined the ability of selection and control flies to successfully clear bacterial (*Ecc15*) infections over a 6‐day period postinfection. The ability of control flies to clear an infection was higher than that of long‐lived flies at young age but declined at old age; in contrast, clearance was overall lower in long‐lived flies yet did not change with age (Fig. [5](#evl389-fig-0005){ref-type="fig"}F). The lower clearance ability of long‐lived selected flies, independent of their age, together with their improved survival upon infection, possibly indicates that they have evolved to be more tolerant to infections than unselected control flies (Best et al. [2008](#evl389-bib-0008){ref-type="ref"}; Ayres and Schneider [2008](#evl389-bib-0004){ref-type="ref"}, [2012](#evl389-bib-0005){ref-type="ref"}; Felix et al. [2012](#evl389-bib-0017){ref-type="ref"}).

REDUCED TOLL SIGNALING EXTENDS LIFESPAN BUT OVERACTIVATION IS DETRIMENTAL {#evl389-sec-0080}
-------------------------------------------------------------------------

Our results above support the idea that improved age‐dependent regulation of immunity contributes to longevity and late‐life fertility, but how immune genes affect lifespan is not well studied, especially in *Drosophila* (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Libert et al. [2006](#evl389-bib-0043){ref-type="ref"}; Fernando et al. [2014](#evl389-bib-0018){ref-type="ref"}; Guo et al. [2014](#evl389-bib-0030){ref-type="ref"}; Kounatidis et al. [2017](#evl389-bib-0036){ref-type="ref"}; Loch et al. [2017](#evl389-bib-0046){ref-type="ref"}). For example, previous work has shown that constitutive upregulation of the peptidoglycan recognition proteins PGRP‐LE and PGRP‐LC causes hyperactivation of Imd signaling and reduces lifespan (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Libert et al. [2006](#evl389-bib-0043){ref-type="ref"}). Similarly, several mutants of negative regulators of Imd signaling display shortened lifespan (Fernando et al. [2014](#evl389-bib-0018){ref-type="ref"}; Kounatidis et al. [2017](#evl389-bib-0036){ref-type="ref"}). While we also identified *PGRP‐LE* as a lifespan candidate gene, most immunity genes in our analysis belong to the Toll pathway (Fig. [3](#evl389-fig-0003){ref-type="fig"}, Table [S4](#evl389-supl-0005){ref-type="supplementary-material"}).

To examine whether Toll signaling affects lifespan, we used transgenic RNAi to silence four longevity candidate genes of the Toll pathway: the ligand *spz*, the receptor *Tl*, the inhibitor *cact*, and the NFκB transcription factor *Dif*. To prevent deleterious side effects of knocking down these developmentally critical genes (Nüsslein‐Volhard and Wieschaus [1980](#evl389-bib-0055){ref-type="ref"}; Belvin and Anderson [1996](#evl389-bib-0007){ref-type="ref"}) we used a mifepristone‐inducible *daughterless* (*da*)‐GeneSwitch(GS)‐GAL4 driver (Tricoire et al. [2009](#evl389-bib-0078){ref-type="ref"}) to direct expression of UAS‐RNAi constructs against these genes specifically during adulthood and throughout the fly body.

Downregulation of the *Tl* receptor--but not of its ligand *spz*--mildly but significantly extended lifespan (Fig. [6](#evl389-fig-0006){ref-type="fig"}A,B,C,D), while silencing the antagonist *cact*--leading to Toll pathway hyperactivation (Lemaitre et al. [1996](#evl389-bib-0040){ref-type="ref"}; Aggarwal and Silverman [2008](#evl389-bib-0001){ref-type="ref"})--drastically reduced lifespan (Fig. [6](#evl389-fig-0006){ref-type="fig"}E,F), similar to the effects of overactivation or derepression of Imd signaling (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Libert et al. [2006](#evl389-bib-0043){ref-type="ref"}; Guo et al. [2014](#evl389-bib-0030){ref-type="ref"}; Kounatidis et al. [2017](#evl389-bib-0036){ref-type="ref"}). Interestingly, we found opposite lifespan effects of *Dif*‐RNAi for females (Fig. [6](#evl389-fig-0006){ref-type="fig"}G) and males (Fig. [6](#evl389-fig-0006){ref-type="fig"}H). In agreement with our findings for females, two studies have previously found that a loss‐of‐function mutant of *Dif* lives longer than wild‐type (Le Bourg et al. [2012](#evl389-bib-0039){ref-type="ref"}; Petersen et al. [2013](#evl389-bib-0062){ref-type="ref"}), but why silencing *Dif* reduces male lifespan remains unclear. Our results thus establish that downregulation of Toll signaling increases lifespan (albeit weakly so), whereas overactivation of this pathway strongly shortens life.

![**Decreased Toll signaling promotes longevity while hyperactivation shortens lifespan. (**A--H) Adult survival upon ubiquitous, adult‐specific transgenic RNAi directed against four canonical components of the Toll signaling pathway: the Toll ligand *spätzle* (*spz*) **(A, B)**, the receptor *Toll* (*Tl*) **(C, D)**, the Toll inhibitor *cactus* (*cact*) **(E, F)**, and the NFκB transcription factor *Dorsal‐related immunity factor* (*Dif*) **(G, H)**. **(A, C, E, G)** show data for female flies and **(B, D, F, H)** represent data for male flies. Silencing the *Tl* receptor **(C, D)** -- but not the *spz* ligand **(A, B)**--extends lifespan, while silencing the antagonist *cact* dramatically shortens lifespan **(E, F)**; silencing *Dif* has opposite effects on female and male lifespan **(G, H)**. For details of statistical analysis using mixed‐effects Cox (proportional hazards) regression see Table [S5](#evl389-supl-0006){ref-type="supplementary-material"}.\
Expression of the different UAS‐RNAi responder constructs was driven with a mifepristone‐inducible *daughterless*(*da*)‐GeneSwitch(GS)‐GAL4 driver. Solid red curves: 200 μg/mL (466 μM) mifepristone (RNAi); dashed curves: 0 μg/mL mifepristone (control). For experimental details see Supplementary methods.](EVL3-2-567-g006){#evl389-fig-0006}

Our findings for the Toll pathway are also consistent with recent studies of IMD signaling showing that lifespan is extended under conditions of reduced lifetime IMD activity (Loch et al. [2017](#evl389-bib-0046){ref-type="ref"}) or when the IMD AMPs *AttacinC* (*AttC*) and *Diptericin B* (*DiptB*) are downregulated in the fat body (Lin et al. [2018](#evl389-bib-0045){ref-type="ref"}). The evidence available to date therefore suggests that decreased activity of the immune system can promote lifespan (DeVeale 2004), possibly by reducing the costs of immune deployment (McKean and Lazzaro [2011](#evl389-bib-0052){ref-type="ref"}). Moreover, as we show here, longer lifespan can evolve -- at least partly -- via evolutionary changes in immunity.

Conclusion {#evl389-sec-0090}
==========

Explaining the genetic basis of variation in longevity is a longstanding problem in evolutionary genetics and the biology of aging (Finch [1990](#evl389-bib-0019){ref-type="ref"}; Rose [1991](#evl389-bib-0069){ref-type="ref"}; Zwaan [1999](#evl389-bib-0085){ref-type="ref"}; Partridge and Gems [2006](#evl389-bib-0059){ref-type="ref"}; Flatt and Schmidt [2009](#evl389-bib-0024){ref-type="ref"}; Flatt and Partridge [2018](#evl389-bib-0023){ref-type="ref"}). Here we have performed a whole‐genome sequencing analysis of an over 35‐year‐long selection experiment for postponed aging and late‐life fertility in *Drosophila* (Luckinbill et al. [1984](#evl389-bib-0048){ref-type="ref"}).

Notably, among the longevity candidate genes identified in our genomic screen, we found an enrichment of immune genes, especially in the Toll pathway. By comparing our data to those from two previous genomic studies of longevity selection in *Drosophila* (Remolina et al. [2012](#evl389-bib-0066){ref-type="ref"}; Carnes et al. [2015](#evl389-bib-0010){ref-type="ref"}) we infer that--while different studies might identify different immune genes as longevity candidates--immune function likely represents a general process‐level mechanism underlying the evolution of longevity assurance and of late‐life performance (Martin et al. [1996](#evl389-bib-0049){ref-type="ref"}; Partridge and Gems [2002](#evl389-bib-0058){ref-type="ref"}; McElwee et al. [2007](#evl389-bib-0051){ref-type="ref"}). This is particularly noteworthy in view of the growing evidence that aging, inflammation and immunity are intricately linked at the molecular level (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"} ; Kurz and Tan [2004](#evl389-bib-0037){ref-type="ref"}; Finch [2007](#evl389-bib-0020){ref-type="ref"}; Salminen et al. [2008](#evl389-bib-0071){ref-type="ref"}; Eleftherianos and Castillo [2012](#evl389-bib-0016){ref-type="ref"}). However, how immunity contributes to longevity and correlated fitness traits is largely unclear.

While aged wild‐type flies upregulate immune gene expression (Pletcher et al. [2002](#evl389-bib-0063){ref-type="ref"}; Seroude et al. [2002](#evl389-bib-0073){ref-type="ref"}; Landis et al. [2004](#evl389-bib-0038){ref-type="ref"}), they typically have a reduced capacity to fight off and survive infections, suggesting that they suffer from immune overactivation and immunopathology (Zerofsky et al. [2005](#evl389-bib-0083){ref-type="ref"}; Ren et al. [2007](#evl389-bib-0067){ref-type="ref"}; Ramsden et al. [2008](#evl389-bib-0064){ref-type="ref"}). Here, we show that long‐lived flies, by contrast, tend to downregulate the induction of immune effector genes (AMPs) with age yet have substantially improved survivorship upon infection. This seems to confirm that elevated immune gene expression at old age might either be ineffective or even detrimental, perhaps as a consequence of senescent dysregulation of gene expression (Zerofsky et al. [2005](#evl389-bib-0083){ref-type="ref"}; Khan et al. [2017](#evl389-bib-0033){ref-type="ref"}). The downregulation of AMPs seen in the long‐lived selection lines might also be a byproduct of selection for late‐life fertility in these lines since elevated AMP expression upon infection is known to reduce fecundity (Zerofsky et al. [2005](#evl389-bib-0083){ref-type="ref"}).

Since optimal immunity depends on the balance between efficient clearance of pathogens and limiting immunity‐induced damage (Cassedevall and Pirofski [1999](#evl389-bib-0011){ref-type="ref"}; Read et al. [2008](#evl389-bib-0065){ref-type="ref"}; Råberg et al. [2009](#evl389-bib-0070){ref-type="ref"}; Medzhitov et al. [2012](#evl389-bib-0053){ref-type="ref"}), we propose that selection for longevity and late‐life fertility leads to improved age‐dependent immune homeostasis and alleviates the trade‐off between immunity and immunopathology. This trade‐off can be decoupled to some degree by tolerance mechanisms (Medzhitov et al. [2012](#evl389-bib-0053){ref-type="ref"}), suggesting that the improved immunity of long‐lived flies might--at least in part--be due to increased tolerance. In line with the notion of a trade‐off between immunity and immunity‐induced damage, work in the mealworm beetle shows that deployment of the immune effector phenoloxidase (PO) causes early‐life inflammation, faster aging, and immunopathology at old age, whereas RNAi silencing of PO extends lifespan and improves survival after infection (Khan et al. [2017](#evl389-bib-0033){ref-type="ref"}). This is consistent with the fact that hyperactivation or derepression of Imd signaling (DeVeale et al. [2004](#evl389-bib-0015){ref-type="ref"}; Libert et al. [2006](#evl389-bib-0043){ref-type="ref"}; Fernando et al. [2014](#evl389-bib-0018){ref-type="ref"}; Kounatidis et al. [2017](#evl389-bib-0036){ref-type="ref"}) and, as we observe here, of Toll signaling reduces lifespan. Conversely, we find that adult downregulation of Toll signaling mildly promotes lifespan, similar to recent findings for the Imd pathway (Kounatidis et al. [2017](#evl389-bib-0036){ref-type="ref"}; Lin et al. [2018](#evl389-bib-0045){ref-type="ref"}).

Together, our work reveals the existence of a causal--but mechanistically still poorly understood--link between improved age‐dependent immunity and the evolution of longevity and late‐life fertility (Garschall and Flatt [2018](#evl389-bib-0025){ref-type="ref"}). This relationship clearly warrants further mechanistic and evolutionary study.

Methods {#evl389-sec-0100}
=======

All methods are given in the Supplementary methods file (see Supporting Information section below), including details of selection and control lines, next‐generation sequencing, bioinformatic, and statistical analyses, gene expression analyses, immunity assays, transgenic RNAi, and lifespan assays.
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